XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 30, 2023
Dec. 24, 2022
Operating activities:    
Net earnings $ 7,282,000 $ 6,633,000
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation of fixed assets 15,176,000 13,476,000
Amortization of intangibles and deferred costs 1,616,000 1,705,000
Gains from disposals of property & equipment (23,000) (711,000)
Share-based compensation 1,480,000 1,239,000
Deferred income taxes (192,000) (526,000)
Loss on marketable securities 0 37,000
Other 157,000 (18,000)
Changes in assets and liabilities, net of effects from purchase of companies    
Decrease in accounts receivable 32,407,000 21,171,000
(Increase) in inventories (971,000) (2,284,000)
Decrease in prepaid expenses 2,625,000 2,343,000
(Decrease) in accounts payable and accrued liabilities (10,604,000) (21,655,000)
Net cash provided by operating activities 48,953,000 21,410,000
Investing activities:    
Purchases of property, plant and equipment (19,930,000) (30,910,000)
Proceeds from redemption and sales of marketable securities 0 3,300,000
Proceeds from disposal of property and equipment 82,000 729,000
Net cash used in investing activities (19,848,000) (26,881,000)
Financing activities:    
Proceeds from issuance of stock 4,481,000 1,285,000
Borrowings under credit facility 15,000,000 72,000,000
Repayment of borrowings under credit facility (35,000,000) (35,000,000)
Payments on finance lease obligations (85,000) (39,000)
Payment of cash dividends (14,209,000) (13,453,000)
Net cash provided by (used in) financing activities (29,813,000) 24,793,000
Effect of exchange rates on cash and cash equivalents 1,147,000 363,000
Net increase in cash and cash equivalents 439,000 19,685,000
Cash and cash equivalents at beginning of period 49,581,000 35,181,000
Cash and cash equivalents at end of period $ 50,020,000 $ 54,866,000